Prosecution Insights
Last updated: August 18, 2026
Application No. 18/646,066

TAMPON PRODUCT INCLUDING APPLICATOR HAVING COMPONENTS MOLDED OF PULP-BASED COMPOSITE

Final Rejection §DP
Filed
Apr 25, 2024
Priority
Mar 22, 2021 — provisional 63/163,985 +1 more
Examiner
SU, SUSAN SHAN
Art Unit
3781
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Procter & Gamble Company
OA Round
2 (Final)
72%
Grant Probability
Favorable
3-4
OA Rounds
10m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
805 granted / 1120 resolved
+1.9% vs TC avg
Strong +24% interview lift
Without
With
+23.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
47 currently pending
Career history
1154
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
49.4%
+9.4% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
22.0%
-18.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1120 resolved cases

Office Action

§DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-20 are pending, of which Claim 2 is amended. All claims are examined on the merits. No new matter is found. Response to Arguments Applicant’s arguments, filed 7/7/2026, with respect to the rejection of the claims in view of Jarmon (US 2003/0105421) and Tojo (US 7,048,975) have been fully considered and are persuasive. The prior art rejection of all claims has been withdrawn. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-2, 8-9, and 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 2, 8-9, & 20 of U.S. Patent No. 12,004,929. Although the claims at issue are not identical, they are not patentably distinct from each other because 2 or 20 recites all limitations in current claims 1, the difference being that patented claim 2 recites the additional limitation of a mean void thickness being 50-300 µm and patented claim 20 recites the additional detail of the ejection plunger being molded from the same composite. Patented claims 2 & 20 also render obvious the current claim 2 because the patented mean void thickness range of 50-300 µm substantially overlaps with the claimed range of 60-200 µm. Patented claims 8-9 read on the current claims 8-9, respectively. Patented claims 2 & 20 read on the current claim 20, where both patented claims have the additional recitation regarding the mean void thickness being 50-300 µm. Allowable Subject Matter Claims 1-20 contain allowable subject matter. Note the nonstatutory double patenting rejection on some claims. The following is a statement of reasons for the indication of allowable subject matter: Applicant arguments filed on 7/7/2026 are persuasive. No other prior art is found to disclose the claimed invention. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SUSAN S SU whose telephone number is (408)918-7575. The examiner can normally be reached M-F 9:00 - 5:00 Pacific. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Rebecca Eisenberg can be reached at 571-270-5879. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SUSAN S SU/Primary Examiner, Art Unit 3781 30 July 2026
Read full office action

Prosecution Timeline

Apr 25, 2024
Application Filed
Apr 09, 2026
Non-Final Rejection mailed — §DP
Jul 07, 2026
Response Filed
Aug 04, 2026
Final Rejection mailed — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702811
FLUID CONNECTOR ASSEMBLY
3y 1m to grant Granted Aug 11, 2026
Patent 12702594
ADHESIVE NITRIC OXIDE DELIVERY BANDAGE FOR SKIN CONDITION HEALING
2y 11m to grant Granted Aug 11, 2026
Patent 12697281
PUNCTURE PORT, LIQUID STORAGE CONTAINER, PRODUCTION METHOD FOR SAID PUNCTURE PORT, AND PRODUCTION METHOD FOR SAID LIQUID STORAGE CONTAINER
2y 9m to grant Granted Aug 04, 2026
Patent 12678348
TAMPON AND TAMPON APPLICATION WRAPPER
2y 9m to grant Granted Jul 14, 2026
Patent 12673145
SYSTEMS AND METHODS FOR BLOOD PROCESSING WITH A REMOTE COMPUTING DEVICE
3y 9m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
72%
Grant Probability
96%
With Interview (+23.6%)
3y 1m (~10m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1120 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month